Montelukast Ratiopharm (Montelukast Sodium)

Montelukast acts as a selective antagonist of the cysteinyl leukotriene receptor CysLT1. By blocking this receptor, it prevents leukotriene D4 and related mediators from triggering bronchial smooth‑muscle contraction, mucus production, and vascular leakage, thereby reducing airway inflammation and hyper‑responsiveness.

The appropriate dose of Montelukast is determined by the prescribing healthcare professional based on the patient’s age, weight, and specific indication. Dosage regimens may differ for asthma maintenance, allergic rhinitis, or exercise‑induced bronchoconstriction, and should always follow the prescriber’s instructions.

Safety data for Montelukast in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑exacerbated respiratory disease or those who need an adjunct to inhaled therapy, though it may be less potent for acute bronchospasm relief.

Montelukast Ratiopharm tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Montelukast is taken orally, usually as a single tablet once daily in the evening. The tablet can be swallowed whole with water. For patients with swallowing difficulties, the tablet may be chewed or dispersed in a small amount of soft food, following the prescriber’s guidance.

Serious adverse events include allergic reactions such as rash, swelling, or anaphylaxis, and neuropsychiatric effects like agitation, depression, or suicidal thoughts. Patients should seek immediate medical attention if they experience any signs of severe allergy or significant mood changes.

Montelukast is contraindicated in individuals with known hypersensitivity to the active ingredient or any excipients in the formulation. Caution is advised for patients with severe hepatic impairment, active psychiatric disorders, or those taking medications that may significantly alter its metabolism.